Predicting the response to SGLT-2 inhibitors as add-on therapy to multiple day injection insulin with glycated albumin: a pilot study.

Stefano Iuliano,Emanuela A Greco,Maria Mirabelli,Eusebio Chiefari,Patrizia Caroleo,Luigi Puccio,Stefania Giuliano,Daniela P Foti,Antonio Brunetti,Antonio Aversa

Minerva endocrinology（2022）

引用 3|浏览13

暂无评分

摘要

Although limited by the small number of participants, these preliminary findings suggest that GA, rather than HbA1c, could represent a useful and reliable biomarker in T2D to monitor the early glucose-lowering effects of antidiabetic drugs with rapid onset of action, such as SGLT-2 inhibitors and MDI insulin.

查看译文

关键词

multiple day injection insulin,glycated albumin,inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要